Kanova Stock

Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.

Sign up today and learn more about Kanova Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Kanova Stock

Kanova is a biopharmaceutical company that focuses on developing therapeutic antibodies and innovative combination therapies in immuno-oncology and autoimmune diseases.

Funding History

November 2018$115M
July 2023$100M

Management

Founder

Chen Dong

Chief Executive Officer

Yaning Wang

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo